|
|
650 Gateway Boulevard
South San Francisco, CA 94080
phone:650-624-9600
fax:650-624-7540
|
|
| Symbol |
ANSV |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.anesiva.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Development and commercialization of novel therapeutic treatments for pain management. |
|
| Management |
| John P. McLaughlin, CEO and Director; James Z. Huang, President; Patrick A. Broderick, Vice President, General Counsel and Corporate Secretary; Badri Dasu, Vice President, Medical Device Engineering |
| |
|
|
|
|
|
|
|
|
|
|
|
| Description |
|
Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has two product candidates in various stages of development. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
